Swedish Biomimetics 3000 ApS: Financial statements 2021
CVR: 41598549
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Swedish Biomimetics 3000 ApS (CVR 41598549) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -2,981,813 and a net result of DKK -9,868,231. Equity in the 2021 report amounted to DKK 86,822,304. The solvency ratio was 76.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -2,981,813
- Profit/Loss
- DKK -9,868,231
- Equity
- DKK 86,822,304
- Total Assets
- DKK 114,040,174
- Employees
- 2
Official annual report
Find more companies like Swedish Biomimetics 3000 ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of September 2, 2021, Thomas James Podkolinski is registered as director of Swedish Biomimetics 3000 ApS.
As of August 25, 2021, Zsolt Lavotha has stepped down as director of Swedish Biomimetics 3000 ApS.
Swedish Biomimetics 3000 ApS has published its interim report for the period August 13, 2020 to December 31, 2020.
About Swedish Biomimetics 3000 ApS
Swedish Biomimetics 3000 ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2020. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by Medical Newsstar AB and Swedish Biomimetics 3000 AB. The company has 1 employee (2022). In 2021, the company reported a gross profit of DKK -2,981,813 and a net result of DKK -9,868,231. Equity in the 2021 report amounted to DKK 86,822,304.